Related Experiment Video
Updated: May 23, 2026

Treatment Model for Young Patients with Psychogenic Erectile Dysfunction and Resultant Infertility
Published on: May 30, 2025
Efficacy of Solifenacin on Overactive Bladder Symptoms, Symptom Bother, and Other Patient-Reported Outcomes in
Michael D Vardy1, H David Mitcheson, Terri-Ann Samuels
1From the *Department of Obstetrics, Gynecology, and Reproductive Science, Mount Sinai School of Medicine, Riverdale, NY; †Englewood Hospital, Englewood, NJ; ‡Bay State Clinical Trials, Inc, Watertown, MA; §Department of Obstetrics, Gynecology, and Reproductive Science, Mount Sinai School of Medicine, New York, NY; ∥GlaxoSmithKline, King of Prussia, PA; and ¶Astellas Pharma US, Inc, Deerfield, IL.
Objective:
: To evaluate the efficacy of solifenacin versus placebo by baseline continence status using post hoc analysis.
Methods:
: Patients with overactive bladder (OAB) were randomized to solifenacin or placebo for 12 weeks; patient-reported outcome (PRO) measures and bladder diaries were completed at prespecified time points. VESIcare Investigation of Bother and Quality of Life in Subjects with OAB (VIBRANT) was not designed to show treatment differences within continence status subgroups.
Results:
: In the full analysis set (n = 750), 73% of patients were incontinent (n = 545) at baseline. After 12 weeks, incontinent patients receiving solifenacin showed significant improvements versus placebo on PRO measures and most diary-based end points; continent patients (n = 205) showed smaller but similar treatment-related changes. Tolerability was similar in both subgroups and by treatment; most frequent adverse events were dry mouth and constipation.
Conclusions:
: In the VIBRANT study, solifenacin significantly improved OAB symptom bother, health-related quality of life, and most symptoms versus placebo in incontinent patients. Continent patients showed smaller but similar trends. Solifenacin was well tolerated in both subgroups.
Related Concept Videos
Urodynamic Studies: Uroflowmetry
Urinary Bladder
In males, the bladder is situated in front of the rectum, while in females, it is positioned anterior to the vagina and uterus. The bladder floor contains an inverted triangular area called the trigone, defined by the two ureteric...
Urinary Tract Calculi III: Medical Management
Drugs for Treatment of Diarrhea-Predominant IBS
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
Imaging Studies VI: Voiding Cystourethrography and Cystography
Drugs for Treatment of Constipation-Predominant IBS